Does Robaxin show up on a drug test? 

Does Robaxin show up on a drug test? 

No, Robaxin (Methocarbamol) does not show up on a drug test. Robaxin is a muscle relaxant and is not considered a drug of abuse as this medication does not cause any type of addiction. 

This is why it is not likely for Robaxin to show up on a drug test and there is no such case reported. 

Robaxin is also not associated with causing a false positive for any other drug of abuse or controlled substance – and the drug is not something the standard 12-panel drug test is focused on. 

However, Robaxin can show up in a urine test if the test is specifically done to check the concentration or presence of this medication in your body. As long as normal drug tests are concerned, the drug will not show up. 

How is Robaxin different from the drugs that are detected in a drug test?

Robaxin, also known as Methocarbamol, is a muscle relaxant that works by blocking pain signals from the nerves to the brain (1,2). It is different from drugs that are typically detected in drug tests because it does not belong to the same class of substances.

Drug tests commonly screen for illicit drugs such as Marijuana (THC), Cocaine, Amphetamines, Opioids (Heroin, Oxycodone), and Benzodiazepines (Xanax, Klonopin, Valium). These drugs are often sought after for their recreational or abuse potential (3,4).

Robaxin, on the other hand, is not a drug of abuse and is not typically included in standard drug tests. It is a prescription medication used for its muscle relaxant properties to alleviate muscle spasms and associated pain.

It’s important to note that while Robaxin is not typically screened for in drug tests, it is still essential to disclose all medications you are taking, including Robaxin, to the testing agency or healthcare provider performing the drug test. 

Final words

To sum up, Robaxin does not show up on a drug test and it’s not something a standard drug test looks for. If you generally have concerns about drug testing and the medications you are taking, it is advisable to consult your healthcare provider or the testing agency.

Was this helpful?

Thanks for your feedback!



Sibrack J, Hammer R. Methocarbamol. 2022 Nov 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 33351427.


Emrich OM, Milachowski KA, Strohmeier M. Methocarbamol bei akuten Rückenschmerzen : Eine randomisierte, doppelblinde, placebokontrollierte Studie MMW Fortschr Med. 2015 Jul;157 Suppl 5:9-16. German. doi: 10.1007/s15006-015-3307-x. Epub 2015 Jul 13. Erratum in: MMW Fortschr Med. 2019 Oct;161(Suppl 6):2. PMID: 26168743.


McNeil SE, Chen RJ, Cogburn M. Drug Testing. 2023 Jan 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 29083751.


Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008 Jan;83(1):66-76. doi: 10.4065/83.1.66. Erratum in: Mayo Clin Proc. 2008 Jul;83(7):851. PMID: 18174009.